EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stimulant Treatment Gap in ADHD Patients with Heroin Use Disorder: Clinical and Behavioural Consequences

Alessandro Pallucchini iD, Maurizio Varese, Irene Pergentini, Samuele Gemignani iD, Elisa Parapetto, Icro Maremmani iD, Angelo Giovanni Icro Maremmani iD

International Journal of Environmental Research and Public Health · 2025

DOI: 10.3390/ijerph23010040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2025. Verfasst von Alessandro Pallucchini und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Addictions, Section of Addictions, North-Western Tuscany Local Health Unit, Apuan Zone, Via Carriona 245, 54033 Carrara,…. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Heroin Dependence, Central Nervous System Stimulants. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adults with attention-deficit/hyperactivity disorder (ADHD) often have comorbid substance use disorders (SUDs). In Italy, individuals with both ADHD and heroin use disorder (HUD) are usually treated in addiction services with opioid agonist therapy (OAT), but stimulant medications are rarely prescribed. This may create a treatment gap for core ADHD symptoms.

Aim

This study examined the clinical and behavioural profiles of ADHD patients with HUD who receive OAT but no stimulant treatment, compared to ADHD patients without opioid use disorder (ADHD/NoHUD) on standard pharmacotherapy. All participants were considered treatment responders in their respective services.

Methods

Data were collected from two outpatient clinics and included 103 adult ADHD patients assessed using validated tools for symptom severity, emotional dysregulation, and global functioning. Differences between groups were analysed using univariate tests and logistic regression.

Results

The ADHD+HUD group was significantly older and showed higher levels of emotional dysregulation, impulsivity, and current cocaine use. Despite clinical stability, these individuals presented a more severe psychopathological profile than their ADHD/NoHUD counterparts, who received stimulant-based treatment.

Conclusions

Although limited by its cross-sectional nature and setting-related confounders, the study indicates that OAT alone may not be sufficient to manage neurodevelopmental symptoms in ADHD+HUD patients. Further research is necessary to assess the safety and efficacy of integrated stimulant-based treatments, ideally within dual disorder services combining psychiatric and addiction expertise.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityHeroin DependenceCentral Nervous System StimulantsHumansMaleAdultFemaleItalyCross-Sectional StudiesMiddle AgedComorbidity

Stichwörter der Autor:innen

ADHDdual disorderheroin use disorderopioid agonist therapystimulant treatment

Substanzen

Central Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Psychiatry and Addictions, Section of Addictions, North-Western Tuscany Local Health Unit, Apuan Zone, Via Carriona 245, 54033 Carrara, Italy.
  • Department of Psychiatry and Addictions, Section of Addictions, North-Western Tuscany Local Health Unit, Lucca Zone, Viale Marti 263, 55100 Lucca, Italy.
  • V.P. Dole Research Group, G. De Lisio Institute of Behavioural Sciences, Via di Pratale 3, 56121 Pisa, Italy.
  • Department of Psychiatry and Addictions, Section of Addictions, North-Western Tuscany Local Health Unit, Livorno Zone, Via Tiberio Scali 11, 57121 Livorno, Italy.
  • Saint Camillus International University of Health Sciences, Via di Sant'Alessandro 8, 00131 Rome, Italy.

ORCID-Profile: Alessandro Pallucchini, Samuele Gemignani, Icro Maremmani, Angelo Giovanni Icro Maremmani

Zitieren

APA

Pallucchini, A., Varese, M., Pergentini, I., Gemignani, S., Parapetto, E., Maremmani, I., & Maremmani, A. G. I. (2025). Stimulant Treatment Gap in ADHD Patients with Heroin Use Disorder: Clinical and Behavioural Consequences. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph23010040

Vancouver

Pallucchini A, Varese M, Pergentini I, Gemignani S, Parapetto E, Maremmani I, et al. Stimulant Treatment Gap in ADHD Patients with Heroin Use Disorder: Clinical and Behavioural Consequences. International Journal of Environmental Research and Public Health. 2025. doi:10.3390/ijerph23010040

BibTeX
@article{Pallucchini2025,
  author = {Pallucchini, Alessandro and Varese, Maurizio and Pergentini, Irene and Gemignani, Samuele and Parapetto, Elisa and Maremmani, Icro and Maremmani, Angelo Giovanni Icro},
  title = {Stimulant Treatment Gap in ADHD Patients with Heroin Use Disorder: Clinical and Behavioural Consequences},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2025},
  doi = {10.3390/ijerph23010040}
}
Kostenlos starten →